

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neurofilament cytoskeleton organization (GO:0060052) | 7.38458094 |
| 2 | negative regulation of dendrite morphogenesis (GO:0050774) | 6.39167767 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 6.36153216 |
| 4 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 5.91334231 |
| 5 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 5.91334231 |
| 6 | base-excision repair, AP site formation (GO:0006285) | 5.80359380 |
| 7 | detection of temperature stimulus (GO:0016048) | 5.70430592 |
| 8 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 5.68722155 |
| 9 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.58748245 |
| 10 | purine deoxyribonucleotide catabolic process (GO:0009155) | 5.54382275 |
| 11 | negative regulation of B cell apoptotic process (GO:0002903) | 5.35449004 |
| 12 | peripheral nervous system neuron development (GO:0048935) | 5.30306425 |
| 13 | deoxyribonucleotide catabolic process (GO:0009264) | 5.28864322 |
| 14 | ncRNA 3-end processing (GO:0043628) | 5.13343434 |
| 15 | deoxyribose phosphate catabolic process (GO:0046386) | 4.93804269 |
| 16 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.84287494 |
| 17 | NADH dehydrogenase complex assembly (GO:0010257) | 4.84287494 |
| 18 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.84287494 |
| 19 | pyrimidine nucleotide catabolic process (GO:0006244) | 4.82733714 |
| 20 | ubiquinone biosynthetic process (GO:0006744) | 4.81448890 |
| 21 | seminiferous tubule development (GO:0072520) | 4.71095860 |
| 22 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 4.68843481 |
| 23 | ubiquinone metabolic process (GO:0006743) | 4.42033339 |
| 24 | protein complex biogenesis (GO:0070271) | 4.40062634 |
| 25 | chaperone-mediated protein transport (GO:0072321) | 4.33642528 |
| 26 | protein maturation by protein folding (GO:0022417) | 4.33517235 |
| 27 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 4.32420045 |
| 28 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.28181428 |
| 29 | neuronal action potential (GO:0019228) | 4.27799681 |
| 30 | viral transcription (GO:0019083) | 4.27544726 |
| 31 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.20289619 |
| 32 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 4.08226877 |
| 33 | ribosomal small subunit biogenesis (GO:0042274) | 4.05042239 |
| 34 | translational termination (GO:0006415) | 4.03574815 |
| 35 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.01440782 |
| 36 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.96362397 |
| 37 | ATP synthesis coupled proton transport (GO:0015986) | 3.86694768 |
| 38 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.86694768 |
| 39 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.86493581 |
| 40 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.83602594 |
| 41 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.83483324 |
| 42 | quinone biosynthetic process (GO:1901663) | 3.83382923 |
| 43 | rRNA modification (GO:0000154) | 3.81152528 |
| 44 | sequestering of actin monomers (GO:0042989) | 3.78780365 |
| 45 | protein polyglutamylation (GO:0018095) | 3.78073313 |
| 46 | deoxyribose phosphate metabolic process (GO:0019692) | 3.76827189 |
| 47 | response to misfolded protein (GO:0051788) | 3.74862759 |
| 48 | cellular response to nicotine (GO:0071316) | 3.72344378 |
| 49 | plasma membrane repair (GO:0001778) | 3.67833173 |
| 50 | respiratory electron transport chain (GO:0022904) | 3.65686602 |
| 51 | regulation of translational termination (GO:0006449) | 3.64590452 |
| 52 | inner mitochondrial membrane organization (GO:0007007) | 3.62371205 |
| 53 | Golgi transport vesicle coating (GO:0048200) | 3.59613041 |
| 54 | COPI coating of Golgi vesicle (GO:0048205) | 3.59613041 |
| 55 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.58975887 |
| 56 | electron transport chain (GO:0022900) | 3.58594465 |
| 57 | translational elongation (GO:0006414) | 3.58149650 |
| 58 | purine ribonucleotide transport (GO:0015868) | 3.58105321 |
| 59 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.54518140 |
| 60 | GDP-mannose metabolic process (GO:0019673) | 3.51194680 |
| 61 | negative regulation of dendrite development (GO:2000171) | 3.50239121 |
| 62 | negative regulation of cell cycle arrest (GO:0071157) | 3.48786349 |
| 63 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.46211159 |
| 64 | autophagic vacuole fusion (GO:0000046) | 3.45038602 |
| 65 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.43966390 |
| 66 | regulation of platelet aggregation (GO:0090330) | 3.43799759 |
| 67 | respiratory chain complex IV assembly (GO:0008535) | 3.43716398 |
| 68 | purine nucleotide salvage (GO:0032261) | 3.43359499 |
| 69 | cell migration in hindbrain (GO:0021535) | 3.41507211 |
| 70 | adenine nucleotide transport (GO:0051503) | 3.40674505 |
| 71 | DNA integration (GO:0015074) | 3.38652788 |
| 72 | membrane depolarization during action potential (GO:0086010) | 3.38218949 |
| 73 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.37841390 |
| 74 | meiotic chromosome segregation (GO:0045132) | 3.35928201 |
| 75 | cotranslational protein targeting to membrane (GO:0006613) | 3.32467583 |
| 76 | deoxyribonucleotide metabolic process (GO:0009262) | 3.30616266 |
| 77 | maturation of SSU-rRNA (GO:0030490) | 3.29826765 |
| 78 | intermediate filament organization (GO:0045109) | 3.28977859 |
| 79 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.26375749 |
| 80 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.26258203 |
| 81 | L-fucose catabolic process (GO:0042355) | 3.25927610 |
| 82 | fucose catabolic process (GO:0019317) | 3.25927610 |
| 83 | L-fucose metabolic process (GO:0042354) | 3.25927610 |
| 84 | protein targeting to ER (GO:0045047) | 3.25608671 |
| 85 | negative regulation of bone resorption (GO:0045779) | 3.23886661 |
| 86 | protein retention in ER lumen (GO:0006621) | 3.21820587 |
| 87 | oxidative phosphorylation (GO:0006119) | 3.20864267 |
| 88 | peptidyl-histidine modification (GO:0018202) | 3.19869034 |
| 89 | membrane budding (GO:0006900) | 3.19205392 |
| 90 | cytochrome complex assembly (GO:0017004) | 3.17915187 |
| 91 | potassium ion export (GO:0071435) | 3.16794567 |
| 92 | protein localization to endoplasmic reticulum (GO:0070972) | 3.16587944 |
| 93 | ER overload response (GO:0006983) | 3.16510197 |
| 94 | cellular protein complex disassembly (GO:0043624) | 3.15325561 |
| 95 | behavioral response to pain (GO:0048266) | 3.15128981 |
| 96 | pseudouridine synthesis (GO:0001522) | 3.11552470 |
| 97 | protein-cofactor linkage (GO:0018065) | 3.11055796 |
| 98 | nucleoside transmembrane transport (GO:1901642) | 3.08664210 |
| 99 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.08638140 |
| 100 | positive regulation of nuclease activity (GO:0032075) | 3.08204650 |
| 101 | regulation of dopamine metabolic process (GO:0042053) | 3.06706944 |
| 102 | regulation of catecholamine metabolic process (GO:0042069) | 3.06706944 |
| 103 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.04483146 |
| 104 | cell communication involved in cardiac conduction (GO:0086065) | 3.04112027 |
| 105 | adenosine metabolic process (GO:0046085) | 3.03870195 |
| 106 | activated T cell proliferation (GO:0050798) | 3.03046714 |
| 107 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.03010471 |
| 108 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.02577950 |
| 109 | DNA damage response, detection of DNA damage (GO:0042769) | 3.01083431 |
| 110 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.00248107 |
| 111 | regulation of penile erection (GO:0060405) | 2.99678512 |
| 112 | aerobic respiration (GO:0009060) | 2.98720305 |
| 113 | actin filament capping (GO:0051693) | 2.98284898 |
| 114 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.97556413 |
| 115 | protein complex disassembly (GO:0043241) | 2.94113039 |
| 116 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.93915589 |
| 117 | nucleoside transport (GO:0015858) | 2.93139514 |
| 118 | modulation by virus of host process (GO:0019054) | 2.91246971 |
| 119 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.91012424 |
| 120 | exocrine pancreas development (GO:0031017) | 2.90932865 |
| 121 | response to ATP (GO:0033198) | 2.89643153 |
| 122 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.87506935 |
| 123 | termination of RNA polymerase III transcription (GO:0006386) | 2.87506935 |
| 124 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.86273067 |
| 125 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.85720576 |
| 126 | response to water (GO:0009415) | 2.85703583 |
| 127 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.83750283 |
| 128 | base-excision repair (GO:0006284) | 2.83730254 |
| 129 | viral life cycle (GO:0019058) | 2.83407979 |
| 130 | intermediate filament cytoskeleton organization (GO:0045104) | 2.81790893 |
| 131 | intracellular protein transmembrane import (GO:0044743) | 2.81417195 |
| 132 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.81048637 |
| 133 | nucleotide salvage (GO:0043173) | 2.80106023 |
| 134 | positive regulation of prostaglandin secretion (GO:0032308) | 2.79217604 |
| 135 | intermediate filament-based process (GO:0045103) | 2.79076076 |
| 136 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.77179026 |
| 137 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.77179026 |
| 138 | regulation of nuclease activity (GO:0032069) | 2.77133824 |
| 139 | proline transport (GO:0015824) | 2.76516794 |
| 140 | negative regulation of actin filament polymerization (GO:0030837) | 2.75194486 |
| 141 | secondary metabolite biosynthetic process (GO:0044550) | 2.74126437 |
| 142 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.74030489 |
| 143 | regulation of B cell apoptotic process (GO:0002902) | 2.73650611 |
| 144 | regulation of early endosome to late endosome transport (GO:2000641) | 2.72291749 |
| 145 | COPII vesicle coating (GO:0048208) | 2.69498560 |
| 146 | macromolecular complex disassembly (GO:0032984) | 2.69453172 |
| 147 | UV protection (GO:0009650) | 2.69362550 |
| 148 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.68306244 |
| 149 | DNA strand elongation (GO:0022616) | 2.66346094 |
| 150 | establishment of protein localization to mitochondrion (GO:0072655) | 2.65957577 |
| 151 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.65591681 |
| 152 | positive regulation of muscle hypertrophy (GO:0014742) | 2.65591681 |
| 153 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.64402145 |
| 154 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.64402145 |
| 155 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.64047042 |
| 156 | negative regulation of telomere maintenance (GO:0032205) | 2.63859278 |
| 157 | transcription from RNA polymerase I promoter (GO:0006360) | 2.63818534 |
| 158 | ER-nucleus signaling pathway (GO:0006984) | 2.63692558 |
| 159 | sodium ion transmembrane transport (GO:0035725) | 2.61708850 |
| 160 | membrane repolarization (GO:0086009) | 2.60354136 |
| 161 | negative regulation of complement activation (GO:0045916) | 2.60161335 |
| 162 | neuronal action potential propagation (GO:0019227) | 2.59959156 |
| 163 | response to pain (GO:0048265) | 2.59584267 |
| 164 | cellular response to unfolded protein (GO:0034620) | 2.57838065 |
| 165 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.54221365 |
| 166 | negative regulation of bone remodeling (GO:0046851) | 2.50555126 |
| 167 | cytidine metabolic process (GO:0046087) | 2.50148217 |
| 168 | cytidine catabolic process (GO:0006216) | 2.50148217 |
| 169 | cytidine deamination (GO:0009972) | 2.50148217 |
| 170 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.48813173 |
| 171 | insulin secretion (GO:0030073) | 2.45764477 |
| 172 | endoplasmic reticulum organization (GO:0007029) | 2.45499338 |
| 173 | intestinal epithelial cell development (GO:0060576) | 2.44775406 |
| 174 | neuron fate specification (GO:0048665) | 2.43599533 |
| 175 | sodium ion export (GO:0071436) | 2.43412628 |
| 176 | sensory perception of taste (GO:0050909) | 2.43218706 |
| 177 | negative regulation of protein polymerization (GO:0032272) | 2.42276918 |
| 178 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.42119486 |
| 179 | sequestering of metal ion (GO:0051238) | 2.41849074 |
| 180 | cellular response to topologically incorrect protein (GO:0035967) | 2.38983950 |
| 181 | regulation of histone phosphorylation (GO:0033127) | 2.38212790 |
| 182 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.36504469 |
| 183 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.36417007 |
| 184 | axon cargo transport (GO:0008088) | 2.35957440 |
| 185 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.33540760 |
| 186 | regulation of relaxation of muscle (GO:1901077) | 2.32237008 |
| 187 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.31763779 |
| 188 | negative regulation of protein activation cascade (GO:2000258) | 2.29580780 |
| 189 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.29539614 |
| 190 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.29454467 |
| 191 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.28246923 |
| 192 | enteric nervous system development (GO:0048484) | 2.27467926 |
| 193 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.27216897 |
| 194 | glucose 6-phosphate metabolic process (GO:0051156) | 2.26686319 |
| 195 | antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886) | 2.26652368 |
| 196 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.25469989 |
| 197 | low-density lipoprotein particle remodeling (GO:0034374) | 2.25382184 |
| 198 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.25002854 |
| 199 | positive thymic T cell selection (GO:0045059) | 2.24337688 |
| 200 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:000250 | 2.24167152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.74165100 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 3.50386484 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.10723659 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.01516557 |
| 5 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.73158248 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.71991002 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.71795685 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.62572103 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.59320014 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.57441607 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.55042185 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.53767272 |
| 13 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.48162869 |
| 14 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.43657471 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.39654717 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.39592790 |
| 17 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.36009725 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.35764724 |
| 19 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.26584593 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.25380410 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.24417582 |
| 22 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.23224386 |
| 23 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.19939973 |
| 24 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.18247266 |
| 25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.17486926 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.07151330 |
| 27 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.06501015 |
| 28 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.05213590 |
| 29 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.04648731 |
| 30 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.00300259 |
| 31 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.96044377 |
| 32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.95453920 |
| 33 | P68_20966046_ChIP-Seq_HELA_Human | 1.92477697 |
| 34 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.90476230 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.87069952 |
| 36 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.86009854 |
| 37 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.85710084 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.84645882 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.83485401 |
| 40 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.83422979 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.81437862 |
| 42 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.81434361 |
| 43 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.80522479 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.80070927 |
| 45 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.79594832 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.77808223 |
| 47 | GATA1_19941826_ChIP-Seq_K562_Human | 1.76581926 |
| 48 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.76448119 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.76052399 |
| 50 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.75936141 |
| 51 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.75423108 |
| 52 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.74887172 |
| 53 | KDM2B_26808549_Chip-Seq_K562_Human | 1.74406258 |
| 54 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.72403476 |
| 55 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.72061341 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.71272103 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70972574 |
| 58 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.69777727 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.69541796 |
| 60 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.68121954 |
| 61 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.67754811 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.67338857 |
| 63 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.67114582 |
| 64 | MYC_22102868_ChIP-Seq_BL_Human | 1.65857534 |
| 65 | GATA2_19941826_ChIP-Seq_K562_Human | 1.62952153 |
| 66 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.60566598 |
| 67 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.57624339 |
| 68 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.57299325 |
| 69 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.56159632 |
| 70 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.55493515 |
| 71 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.55053250 |
| 72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54880647 |
| 73 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.54685367 |
| 74 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.54311272 |
| 75 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.54294711 |
| 76 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.54189330 |
| 77 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53374113 |
| 78 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52833842 |
| 79 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52589812 |
| 80 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.50346998 |
| 81 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.49473163 |
| 82 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.47602360 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.47576551 |
| 84 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.47522645 |
| 85 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.47144845 |
| 86 | ATF3_27146783_Chip-Seq_COLON_Human | 1.45733542 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.45420441 |
| 88 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.44956862 |
| 89 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.43861998 |
| 90 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.42515275 |
| 91 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.42216793 |
| 92 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.42145376 |
| 93 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.41686085 |
| 94 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.41168772 |
| 95 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.40869473 |
| 96 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.40038907 |
| 97 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.39470436 |
| 98 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.39439559 |
| 99 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39395153 |
| 100 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.37802213 |
| 101 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.36768683 |
| 102 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36529819 |
| 103 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.35141176 |
| 104 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.34280704 |
| 105 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.34264920 |
| 106 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.33855214 |
| 107 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.33211575 |
| 108 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32745856 |
| 109 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.32449779 |
| 110 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.31781969 |
| 111 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31023028 |
| 112 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.30706650 |
| 113 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.30250318 |
| 114 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.29410277 |
| 115 | SA1_27219007_Chip-Seq_Bcells_Human | 1.29383149 |
| 116 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27387513 |
| 117 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.27241306 |
| 118 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.27077359 |
| 119 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.26424228 |
| 120 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.26313340 |
| 121 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26150217 |
| 122 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25816964 |
| 123 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.25186905 |
| 124 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.24671744 |
| 125 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24559228 |
| 126 | P300_27268052_Chip-Seq_Bcells_Human | 1.24409436 |
| 127 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.23172681 |
| 128 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.23022568 |
| 129 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.22615049 |
| 130 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.22600412 |
| 131 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21412366 |
| 132 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.20477166 |
| 133 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.19466995 |
| 134 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.19081508 |
| 135 | * MAF_26560356_Chip-Seq_TH1_Human | 1.18242578 |
| 136 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17321155 |
| 137 | MAF_26560356_Chip-Seq_TH2_Human | 1.16677748 |
| 138 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.16294327 |
| 139 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15969289 |
| 140 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15847559 |
| 141 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.14920179 |
| 142 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.14884301 |
| 143 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.14760062 |
| 144 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.14221580 |
| 145 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.13411760 |
| 146 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13173079 |
| 147 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13113493 |
| 148 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12666218 |
| 149 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12430848 |
| 150 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11694825 |
| 151 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11009445 |
| 152 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10763440 |
| 153 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.10139103 |
| 154 | ERA_21632823_ChIP-Seq_H3396_Human | 1.09988283 |
| 155 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.09610137 |
| 156 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.09027471 |
| 157 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08842392 |
| 158 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.08604692 |
| 159 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08410149 |
| 160 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.07641233 |
| 161 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07474405 |
| 162 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.06891897 |
| 163 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06614080 |
| 164 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06219205 |
| 165 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05998512 |
| 166 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.05158593 |
| 167 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04994758 |
| 168 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04264115 |
| 169 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03863781 |
| 170 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.02142418 |
| 171 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01809224 |
| 172 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.01477259 |
| 173 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.99438491 |
| 174 | MYB_26560356_Chip-Seq_TH2_Human | 0.99057187 |
| 175 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.98216441 |
| 176 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.97817739 |
| 177 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95851701 |
| 178 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.95779118 |
| 179 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.95442206 |
| 180 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.94856367 |
| 181 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.93365225 |
| 182 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93223957 |
| 183 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93222841 |
| 184 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.92680746 |
| 185 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.91334437 |
| 186 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.89136191 |
| 187 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.88759084 |
| 188 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87164285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002735_abnormal_chemical_nociception | 6.30052162 |
| 2 | MP0002736_abnormal_nociception_after | 4.78504014 |
| 3 | MP0001968_abnormal_touch/_nociception | 4.58626795 |
| 4 | MP0004858_abnormal_nervous_system | 4.45032424 |
| 5 | MP0001986_abnormal_taste_sensitivity | 4.19937520 |
| 6 | MP0002733_abnormal_thermal_nociception | 3.27484232 |
| 7 | MP0003656_abnormal_erythrocyte_physiolo | 3.22942766 |
| 8 | MP0001905_abnormal_dopamine_level | 3.20720553 |
| 9 | MP0004270_analgesia | 3.16141376 |
| 10 | MP0005083_abnormal_biliary_tract | 2.86047283 |
| 11 | MP0001529_abnormal_vocalization | 2.77068773 |
| 12 | MP0003787_abnormal_imprinting | 2.72415689 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.71489673 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.69376339 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.61251378 |
| 16 | MP0003693_abnormal_embryo_hatching | 2.57364916 |
| 17 | MP0006036_abnormal_mitochondrial_physio | 2.51684442 |
| 18 | MP0006276_abnormal_autonomic_nervous | 2.48360308 |
| 19 | MP0001970_abnormal_pain_threshold | 2.44731994 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.41791364 |
| 21 | MP0005084_abnormal_gallbladder_morpholo | 2.29293072 |
| 22 | MP0006035_abnormal_mitochondrial_morpho | 2.22730473 |
| 23 | MP0004147_increased_porphyrin_level | 2.19678567 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.18711481 |
| 25 | MP0005377_hearing/vestibular/ear_phenot | 2.17279820 |
| 26 | MP0003878_abnormal_ear_physiology | 2.17279820 |
| 27 | MP0010094_abnormal_chromosome_stability | 2.16525669 |
| 28 | MP0003183_abnormal_peptide_metabolism | 2.04076067 |
| 29 | MP0009697_abnormal_copulation | 2.02674997 |
| 30 | MP0006292_abnormal_olfactory_placode | 1.99173879 |
| 31 | MP0005645_abnormal_hypothalamus_physiol | 1.88265306 |
| 32 | MP0010030_abnormal_orbit_morphology | 1.82765200 |
| 33 | MP0003718_maternal_effect | 1.76214114 |
| 34 | MP0003646_muscle_fatigue | 1.76047071 |
| 35 | MP0003011_delayed_dark_adaptation | 1.73976818 |
| 36 | MP0003303_peritoneal_inflammation | 1.71330189 |
| 37 | MP0008058_abnormal_DNA_repair | 1.70990075 |
| 38 | MP0008007_abnormal_cellular_replicative | 1.66183030 |
| 39 | MP0003136_yellow_coat_color | 1.64139140 |
| 40 | MP0001270_distended_abdomen | 1.63281818 |
| 41 | MP0001348_abnormal_lacrimal_gland | 1.61396651 |
| 42 | MP0004742_abnormal_vestibular_system | 1.60012502 |
| 43 | MP0003315_abnormal_perineum_morphology | 1.59029145 |
| 44 | MP0003868_abnormal_feces_composition | 1.56903647 |
| 45 | MP0003436_decreased_susceptibility_to | 1.56188254 |
| 46 | MP0002254_reproductive_system_inflammat | 1.55796952 |
| 47 | MP0005171_absent_coat_pigmentation | 1.53379206 |
| 48 | MP0003283_abnormal_digestive_organ | 1.51546190 |
| 49 | MP0003121_genomic_imprinting | 1.47239930 |
| 50 | MP0002139_abnormal_hepatobiliary_system | 1.46864306 |
| 51 | MP0002837_dystrophic_cardiac_calcinosis | 1.45480043 |
| 52 | MP0008260_abnormal_autophagy | 1.44524433 |
| 53 | MP0000751_myopathy | 1.43742428 |
| 54 | MP0003329_amyloid_beta_deposits | 1.40977082 |
| 55 | MP0003111_abnormal_nucleus_morphology | 1.40792719 |
| 56 | MP0003045_fibrosis | 1.40046331 |
| 57 | MP0003866_abnormal_defecation | 1.39236618 |
| 58 | MP0002653_abnormal_ependyma_morphology | 1.38775658 |
| 59 | MP0004142_abnormal_muscle_tone | 1.38285240 |
| 60 | MP0002877_abnormal_melanocyte_morpholog | 1.38005310 |
| 61 | MP0002693_abnormal_pancreas_physiology | 1.37817214 |
| 62 | MP0005174_abnormal_tail_pigmentation | 1.35285983 |
| 63 | MP0002909_abnormal_adrenal_gland | 1.33571708 |
| 64 | MP0009780_abnormal_chondrocyte_physiolo | 1.33308099 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 1.31224358 |
| 66 | MP0002751_abnormal_autonomic_nervous | 1.31197854 |
| 67 | MP0010352_gastrointestinal_tract_polyps | 1.30794538 |
| 68 | MP0000604_amyloidosis | 1.29285883 |
| 69 | MP0002160_abnormal_reproductive_system | 1.28768915 |
| 70 | MP0008995_early_reproductive_senescence | 1.26494491 |
| 71 | MP0002822_catalepsy | 1.26492580 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 1.24609811 |
| 73 | MP0009840_abnormal_foam_cell | 1.24472421 |
| 74 | MP0008872_abnormal_physiological_respon | 1.23822200 |
| 75 | MP0003172_abnormal_lysosome_physiology | 1.23576138 |
| 76 | MP0000749_muscle_degeneration | 1.14459767 |
| 77 | MP0003186_abnormal_redox_activity | 1.13579649 |
| 78 | MP0004510_myositis | 1.13418243 |
| 79 | MP0004947_skin_inflammation | 1.11854600 |
| 80 | MP0003077_abnormal_cell_cycle | 1.11040961 |
| 81 | MP0002638_abnormal_pupillary_reflex | 1.09072684 |
| 82 | MP0004133_heterotaxia | 1.07208303 |
| 83 | MP0001485_abnormal_pinna_reflex | 1.06799087 |
| 84 | MP0010307_abnormal_tumor_latency | 1.06139812 |
| 85 | MP0003122_maternal_imprinting | 1.06082242 |
| 86 | MP0004145_abnormal_muscle_electrophysio | 1.05535250 |
| 87 | MP0003191_abnormal_cellular_cholesterol | 1.04417168 |
| 88 | MP0005000_abnormal_immune_tolerance | 1.04368633 |
| 89 | MP0005085_abnormal_gallbladder_physiolo | 1.03189015 |
| 90 | MP0002396_abnormal_hematopoietic_system | 1.02995745 |
| 91 | MP0000015_abnormal_ear_pigmentation | 1.02639820 |
| 92 | MP0002928_abnormal_bile_duct | 1.01225958 |
| 93 | MP0001533_abnormal_skeleton_physiology | 1.00132759 |
| 94 | MP0005253_abnormal_eye_physiology | 0.99647982 |
| 95 | MP0001346_abnormal_lacrimal_gland | 0.99056928 |
| 96 | MP0001944_abnormal_pancreas_morphology | 0.98450880 |
| 97 | MP0000470_abnormal_stomach_morphology | 0.97321575 |
| 98 | MP0002210_abnormal_sex_determination | 0.97214097 |
| 99 | MP0002067_abnormal_sensory_capabilities | 0.96517525 |
| 100 | MP0008932_abnormal_embryonic_tissue | 0.96092269 |
| 101 | MP0001666_abnormal_nutrient_absorption | 0.95847002 |
| 102 | MP0004811_abnormal_neuron_physiology | 0.95321362 |
| 103 | MP0003137_abnormal_impulse_conducting | 0.94232220 |
| 104 | MP0000372_irregular_coat_pigmentation | 0.93070759 |
| 105 | MP0005394_taste/olfaction_phenotype | 0.92957400 |
| 106 | MP0005499_abnormal_olfactory_system | 0.92957400 |
| 107 | MP0009278_abnormal_bone_marrow | 0.91990520 |
| 108 | MP0010386_abnormal_urinary_bladder | 0.91064170 |
| 109 | MP0008961_abnormal_basal_metabolism | 0.90245106 |
| 110 | MP0004957_abnormal_blastocyst_morpholog | 0.90085136 |
| 111 | MP0002166_altered_tumor_susceptibility | 0.89999931 |
| 112 | MP0000358_abnormal_cell_content/ | 0.89973404 |
| 113 | MP0003786_premature_aging | 0.89724485 |
| 114 | MP0005360_urolithiasis | 0.88778629 |
| 115 | MP0000013_abnormal_adipose_tissue | 0.88743256 |
| 116 | MP0003724_increased_susceptibility_to | 0.88724255 |
| 117 | MP0002019_abnormal_tumor_incidence | 0.86361405 |
| 118 | MP0001502_abnormal_circadian_rhythm | 0.86199292 |
| 119 | MP0005058_abnormal_lysosome_morphology | 0.86050854 |
| 120 | MP0005464_abnormal_platelet_physiology | 0.85001784 |
| 121 | MP0002722_abnormal_immune_system | 0.83563506 |
| 122 | MP0001800_abnormal_humoral_immune | 0.83193877 |
| 123 | MP0000049_abnormal_middle_ear | 0.82712155 |
| 124 | MP0003566_abnormal_cell_adhesion | 0.82373757 |
| 125 | MP0002933_joint_inflammation | 0.82213690 |
| 126 | MP0005310_abnormal_salivary_gland | 0.81715246 |
| 127 | MP0005220_abnormal_exocrine_pancreas | 0.81373546 |
| 128 | MP0010155_abnormal_intestine_physiology | 0.80932733 |
| 129 | MP0001835_abnormal_antigen_presentation | 0.80917487 |
| 130 | MP0002184_abnormal_innervation | 0.80698899 |
| 131 | MP0001299_abnormal_eye_distance/ | 0.80377149 |
| 132 | MP0001845_abnormal_inflammatory_respons | 0.80320500 |
| 133 | MP0000689_abnormal_spleen_morphology | 0.80013445 |
| 134 | MP0008789_abnormal_olfactory_epithelium | 0.79943294 |
| 135 | MP0002078_abnormal_glucose_homeostasis | 0.79593801 |
| 136 | MP0001873_stomach_inflammation | 0.79532103 |
| 137 | MP0005451_abnormal_body_composition | 0.78762738 |
| 138 | MP0001188_hyperpigmentation | 0.78621900 |
| 139 | MP0002272_abnormal_nervous_system | 0.77246753 |
| 140 | MP0000750_abnormal_muscle_regeneration | 0.76373219 |
| 141 | MP0009745_abnormal_behavioral_response | 0.75802247 |
| 142 | MP0005387_immune_system_phenotype | 0.74872617 |
| 143 | MP0001790_abnormal_immune_system | 0.74872617 |
| 144 | MP0008877_abnormal_DNA_methylation | 0.74704445 |
| 145 | MP0001145_abnormal_male_reproductive | 0.74518831 |
| 146 | MP0008775_abnormal_heart_ventricle | 0.74310731 |
| 147 | MP0002398_abnormal_bone_marrow | 0.73761219 |
| 148 | MP0000609_abnormal_liver_physiology | 0.72959077 |
| 149 | MP0005076_abnormal_cell_differentiation | 0.71758948 |
| 150 | MP0001663_abnormal_digestive_system | 0.71046547 |
| 151 | MP0001929_abnormal_gametogenesis | 0.70972428 |
| 152 | MP0002723_abnormal_immune_serum | 0.70495897 |
| 153 | MP0005671_abnormal_response_to | 0.70098019 |
| 154 | MP0000026_abnormal_inner_ear | 0.69395589 |
| 155 | MP0009643_abnormal_urine_homeostasis | 0.69383136 |
| 156 | MP0000538_abnormal_urinary_bladder | 0.69097808 |
| 157 | MP0001849_ear_inflammation | 0.68733636 |
| 158 | MP0002249_abnormal_larynx_morphology | 0.67768694 |
| 159 | MP0000653_abnormal_sex_gland | 0.67562867 |
| 160 | MP0002557_abnormal_social/conspecific_i | 0.67356496 |
| 161 | MP0002419_abnormal_innate_immunity | 0.67275441 |
| 162 | MP0003698_abnormal_male_reproductive | 0.67178929 |
| 163 | MP0005535_abnormal_body_temperature | 0.67001643 |
| 164 | MP0002429_abnormal_blood_cell | 0.66397348 |
| 165 | MP0000685_abnormal_immune_system | 0.66384711 |
| 166 | MP0005448_abnormal_energy_balance | 0.64782173 |
| 167 | MP0000955_abnormal_spinal_cord | 0.63752878 |
| 168 | MP0003638_abnormal_response/metabolism_ | 0.62870524 |
| 169 | MP0003879_abnormal_hair_cell | 0.62267361 |
| 170 | MP0008770_decreased_survivor_rate | 0.61596757 |
| 171 | MP0000313_abnormal_cell_death | 0.61571372 |
| 172 | MP0001765_abnormal_ion_homeostasis | 0.61427610 |
| 173 | MP0005025_abnormal_response_to | 0.61260564 |
| 174 | MP0002148_abnormal_hypersensitivity_rea | 0.60860182 |
| 175 | MP0009333_abnormal_splenocyte_physiolog | 0.60540047 |
| 176 | MP0000716_abnormal_immune_system | 0.60308515 |
| 177 | MP0000703_abnormal_thymus_morphology | 0.60142648 |
| 178 | MP0005397_hematopoietic_system_phenotyp | 0.59481416 |
| 179 | MP0001545_abnormal_hematopoietic_system | 0.59481416 |
| 180 | MP0003252_abnormal_bile_duct | 0.58901613 |
| 181 | MP0002229_neurodegeneration | 0.58775683 |
| 182 | MP0002118_abnormal_lipid_homeostasis | 0.58464896 |
| 183 | MP0006082_CNS_inflammation | 0.57086565 |
| 184 | MP0002006_tumorigenesis | 0.57069009 |
| 185 | MP0005166_decreased_susceptibility_to | 0.56404426 |
| 186 | MP0002452_abnormal_antigen_presenting | 0.56246513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ulnar claw (HP:0001178) | 6.10902214 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.51083786 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.31730197 |
| 4 | Dysautonomia (HP:0002459) | 4.31377755 |
| 5 | Mitochondrial inheritance (HP:0001427) | 4.25099693 |
| 6 | Abnormal number of erythroid precursors (HP:0012131) | 4.23401290 |
| 7 | Hepatocellular necrosis (HP:0001404) | 4.14386489 |
| 8 | Testicular atrophy (HP:0000029) | 4.10865465 |
| 9 | Thoracolumbar scoliosis (HP:0002944) | 3.96483687 |
| 10 | Reticulocytopenia (HP:0001896) | 3.95350468 |
| 11 | Termporal pattern (HP:0011008) | 3.94355239 |
| 12 | Insidious onset (HP:0003587) | 3.94355239 |
| 13 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.87842737 |
| 14 | Action tremor (HP:0002345) | 3.77014070 |
| 15 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.70467723 |
| 16 | Increased CSF lactate (HP:0002490) | 3.68914707 |
| 17 | Impaired pain sensation (HP:0007328) | 3.63816386 |
| 18 | Abnormality of pain sensation (HP:0010832) | 3.63816386 |
| 19 | Mesangial abnormality (HP:0001966) | 3.62486466 |
| 20 | Acute encephalopathy (HP:0006846) | 3.60277449 |
| 21 | Hepatic necrosis (HP:0002605) | 3.51714009 |
| 22 | Hypercortisolism (HP:0001578) | 3.48190513 |
| 23 | Increased hepatocellular lipid droplets (HP:0006565) | 3.45630450 |
| 24 | Pheochromocytoma (HP:0002666) | 3.33726715 |
| 25 | Renal Fanconi syndrome (HP:0001994) | 3.29578665 |
| 26 | Progressive macrocephaly (HP:0004481) | 3.29274718 |
| 27 | Microvesicular hepatic steatosis (HP:0001414) | 3.27074963 |
| 28 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.19797353 |
| 29 | Reduced antithrombin III activity (HP:0001976) | 3.13787388 |
| 30 | Increased intramyocellular lipid droplets (HP:0012240) | 3.12580626 |
| 31 | Neuroendocrine neoplasm (HP:0100634) | 3.05530710 |
| 32 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.98520121 |
| 33 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.96963676 |
| 34 | Lipid accumulation in hepatocytes (HP:0006561) | 2.94856101 |
| 35 | Distal arthrogryposis (HP:0005684) | 2.93691100 |
| 36 | Agammaglobulinemia (HP:0004432) | 2.91933160 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.90789995 |
| 38 | Myokymia (HP:0002411) | 2.85656031 |
| 39 | Irregular epiphyses (HP:0010582) | 2.81421620 |
| 40 | Type I transferrin isoform profile (HP:0003642) | 2.80596524 |
| 41 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.78174485 |
| 42 | Abnormality of B cell number (HP:0010975) | 2.76364110 |
| 43 | Foot dorsiflexor weakness (HP:0009027) | 2.76230519 |
| 44 | Failure to thrive in infancy (HP:0001531) | 2.75994996 |
| 45 | B lymphocytopenia (HP:0010976) | 2.73200600 |
| 46 | Increased muscle lipid content (HP:0009058) | 2.72974915 |
| 47 | Hammertoe (HP:0001765) | 2.70009420 |
| 48 | Severe combined immunodeficiency (HP:0004430) | 2.69281076 |
| 49 | Attenuation of retinal blood vessels (HP:0007843) | 2.67943522 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.66391334 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.66391334 |
| 52 | Exertional dyspnea (HP:0002875) | 2.62874200 |
| 53 | Submucous cleft hard palate (HP:0000176) | 2.58496586 |
| 54 | Increased serum lactate (HP:0002151) | 2.57383866 |
| 55 | Hyporeflexia of lower limbs (HP:0002600) | 2.50248420 |
| 56 | Optic disc pallor (HP:0000543) | 2.49255386 |
| 57 | Abnormality of the foot musculature (HP:0001436) | 2.48268789 |
| 58 | Lumbar hyperlordosis (HP:0002938) | 2.47218651 |
| 59 | Cerebral palsy (HP:0100021) | 2.47190184 |
| 60 | Increased CSF protein (HP:0002922) | 2.45742728 |
| 61 | Poikilocytosis (HP:0004447) | 2.44760365 |
| 62 | Cerebral edema (HP:0002181) | 2.41164595 |
| 63 | Absent thumb (HP:0009777) | 2.41082135 |
| 64 | Supranuclear gaze palsy (HP:0000605) | 2.40453187 |
| 65 | Poikiloderma (HP:0001029) | 2.39183803 |
| 66 | Reticulocytosis (HP:0001923) | 2.36546644 |
| 67 | Patellar aplasia (HP:0006443) | 2.35091493 |
| 68 | Flat acetabular roof (HP:0003180) | 2.35078821 |
| 69 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.32897989 |
| 70 | Exercise intolerance (HP:0003546) | 2.30427730 |
| 71 | Hypothermia (HP:0002045) | 2.30334637 |
| 72 | Absent phalangeal crease (HP:0006109) | 2.28812771 |
| 73 | Ventricular fibrillation (HP:0001663) | 2.28551368 |
| 74 | Macrocytic anemia (HP:0001972) | 2.27988931 |
| 75 | Decreased motor nerve conduction velocity (HP:0003431) | 2.27663154 |
| 76 | Abnormal gallbladder morphology (HP:0012437) | 2.23118441 |
| 77 | Acanthocytosis (HP:0001927) | 2.22670279 |
| 78 | Oligomenorrhea (HP:0000876) | 2.22513101 |
| 79 | Arthropathy (HP:0003040) | 2.22162973 |
| 80 | Lactic acidosis (HP:0003128) | 2.22062322 |
| 81 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.21551284 |
| 82 | Increased IgM level (HP:0003496) | 2.21482831 |
| 83 | Cholelithiasis (HP:0001081) | 2.21011984 |
| 84 | Bundle branch block (HP:0011710) | 2.20481112 |
| 85 | Distal sensory impairment (HP:0002936) | 2.19210588 |
| 86 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.19009629 |
| 87 | Pallor (HP:0000980) | 2.17727843 |
| 88 | Thyroid carcinoma (HP:0002890) | 2.17590188 |
| 89 | Acute lymphatic leukemia (HP:0006721) | 2.16943864 |
| 90 | Dyschromatopsia (HP:0007641) | 2.16769418 |
| 91 | Respiratory difficulties (HP:0002880) | 2.16534105 |
| 92 | Congenital stationary night blindness (HP:0007642) | 2.14587950 |
| 93 | Onion bulb formation (HP:0003383) | 2.12595660 |
| 94 | Steppage gait (HP:0003376) | 2.10682701 |
| 95 | Abnormality of the labia minora (HP:0012880) | 2.10671519 |
| 96 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.10521210 |
| 97 | Hand muscle atrophy (HP:0009130) | 2.10100203 |
| 98 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.08942436 |
| 99 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.08942436 |
| 100 | Autoimmune hemolytic anemia (HP:0001890) | 2.08272178 |
| 101 | Areflexia of lower limbs (HP:0002522) | 2.08045084 |
| 102 | Maternal diabetes (HP:0009800) | 2.07965941 |
| 103 | Thoracic kyphosis (HP:0002942) | 2.07536443 |
| 104 | Abnormality of DNA repair (HP:0003254) | 2.07215699 |
| 105 | Bradycardia (HP:0001662) | 2.06816600 |
| 106 | Nasal speech (HP:0001611) | 2.06749243 |
| 107 | Eczematoid dermatitis (HP:0000976) | 2.06457271 |
| 108 | Rib fusion (HP:0000902) | 2.05964997 |
| 109 | 3-Methylglutaconic aciduria (HP:0003535) | 2.05812429 |
| 110 | Abnormality of femoral epiphyses (HP:0006499) | 2.05637864 |
| 111 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.05637864 |
| 112 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.04504171 |
| 113 | 11 pairs of ribs (HP:0000878) | 2.03398344 |
| 114 | Autoimmune thrombocytopenia (HP:0001973) | 2.03307569 |
| 115 | Increased IgE level (HP:0003212) | 2.03306138 |
| 116 | Leukocytosis (HP:0001974) | 2.01725844 |
| 117 | Hypertensive crisis (HP:0100735) | 2.01666031 |
| 118 | Abnormal tarsal ossification (HP:0008369) | 2.01568732 |
| 119 | Colon cancer (HP:0003003) | 2.00154531 |
| 120 | Atonic seizures (HP:0010819) | 1.99834965 |
| 121 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.99263189 |
| 122 | Mask-like facies (HP:0000298) | 1.98736348 |
| 123 | Broad distal phalanx of finger (HP:0009836) | 1.98706324 |
| 124 | Combined immunodeficiency (HP:0005387) | 1.97734162 |
| 125 | Aplastic anemia (HP:0001915) | 1.97265212 |
| 126 | Abnormal foot bone ossification (HP:0010675) | 1.96643086 |
| 127 | Sparse scalp hair (HP:0002209) | 1.96506818 |
| 128 | Protuberant abdomen (HP:0001538) | 1.96254641 |
| 129 | Pendular nystagmus (HP:0012043) | 1.96036099 |
| 130 | Flattened epiphyses (HP:0003071) | 1.95603449 |
| 131 | Meckel diverticulum (HP:0002245) | 1.95406344 |
| 132 | Abnormality of the ileum (HP:0001549) | 1.95267085 |
| 133 | Axonal loss (HP:0003447) | 1.95239897 |
| 134 | Interstitial pulmonary disease (HP:0006530) | 1.95060679 |
| 135 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.94766110 |
| 136 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.93882721 |
| 137 | Abnormality of the ischium (HP:0003174) | 1.93475258 |
| 138 | Molar tooth sign on MRI (HP:0002419) | 1.91649306 |
| 139 | Abnormality of midbrain morphology (HP:0002418) | 1.91649306 |
| 140 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.89975953 |
| 141 | Myotonia (HP:0002486) | 1.89953606 |
| 142 | Distal lower limb muscle weakness (HP:0009053) | 1.89899150 |
| 143 | Cupped ribs (HP:0000887) | 1.89882355 |
| 144 | Global brain atrophy (HP:0002283) | 1.89672692 |
| 145 | Overlapping toe (HP:0001845) | 1.89459216 |
| 146 | Pancytopenia (HP:0001876) | 1.88386511 |
| 147 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.87019303 |
| 148 | Mucopolysacchariduria (HP:0008155) | 1.87019303 |
| 149 | Muscle fiber atrophy (HP:0100295) | 1.86878579 |
| 150 | Abnormality of the intervertebral disk (HP:0005108) | 1.85575384 |
| 151 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.85375815 |
| 152 | Abnormality of the parathyroid morphology (HP:0011766) | 1.85300007 |
| 153 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.85284222 |
| 154 | Abnormality of the femoral head (HP:0003368) | 1.85170995 |
| 155 | Ragged-red muscle fibers (HP:0003200) | 1.84819304 |
| 156 | Generalized hyperpigmentation (HP:0007440) | 1.84414897 |
| 157 | Impaired proprioception (HP:0010831) | 1.83931618 |
| 158 | Impulsivity (HP:0100710) | 1.83706650 |
| 159 | Ovoid vertebral bodies (HP:0003300) | 1.83185331 |
| 160 | Multiple enchondromatosis (HP:0005701) | 1.81696599 |
| 161 | Hyperparathyroidism (HP:0000843) | 1.81529059 |
| 162 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.80892211 |
| 163 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.80892211 |
| 164 | Abnormal protein glycosylation (HP:0012346) | 1.80892211 |
| 165 | Abnormal glycosylation (HP:0012345) | 1.80892211 |
| 166 | Hyperbilirubinemia (HP:0002904) | 1.80857048 |
| 167 | Disproportionate short-trunk short stature (HP:0003521) | 1.80648482 |
| 168 | Autoamputation (HP:0001218) | 1.79664303 |
| 169 | Septo-optic dysplasia (HP:0100842) | 1.78692868 |
| 170 | Respiratory failure (HP:0002878) | 1.78486041 |
| 171 | Episodic fever (HP:0001954) | 1.78463399 |
| 172 | Hyperthyroidism (HP:0000836) | 1.78040771 |
| 173 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.77186914 |
| 174 | Hyperglycinemia (HP:0002154) | 1.76909211 |
| 175 | Abnormality of the preputium (HP:0100587) | 1.76442488 |
| 176 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.75899490 |
| 177 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.75592884 |
| 178 | Panhypogammaglobulinemia (HP:0003139) | 1.74662314 |
| 179 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.74304427 |
| 180 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.74304427 |
| 181 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.74304427 |
| 182 | Urinary urgency (HP:0000012) | 1.74122062 |
| 183 | Menstrual irregularities (HP:0000858) | 1.73736349 |
| 184 | Peripheral demyelination (HP:0011096) | 1.73165312 |
| 185 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.73130995 |
| 186 | Absent radius (HP:0003974) | 1.72608484 |
| 187 | Abnormality of the vocal cords (HP:0008777) | 1.72211430 |
| 188 | Abnormality of the thoracic spine (HP:0100711) | 1.72115968 |
| 189 | Difficulty climbing stairs (HP:0003551) | 1.69478826 |
| 190 | Patent foramen ovale (HP:0001655) | 1.68141379 |
| 191 | Upper limb amyotrophy (HP:0009129) | 1.67855314 |
| 192 | Distal upper limb amyotrophy (HP:0007149) | 1.67855314 |
| 193 | Papilloma (HP:0012740) | 1.67655801 |
| 194 | Verrucae (HP:0200043) | 1.67655801 |
| 195 | Long toe (HP:0010511) | 1.66913751 |
| 196 | Late onset (HP:0003584) | 1.66519411 |
| 197 | Small epiphyses (HP:0010585) | 1.65372990 |
| 198 | Tetraparesis (HP:0002273) | 1.63692524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.30324792 |
| 2 | NME2 | 3.44169763 |
| 3 | NTRK1 | 3.15588607 |
| 4 | LMTK2 | 3.15575276 |
| 5 | BCKDK | 3.12409878 |
| 6 | MAP3K2 | 2.99749843 |
| 7 | RIPK4 | 2.95521282 |
| 8 | TESK2 | 2.77594765 |
| 9 | ERN1 | 2.71986306 |
| 10 | MAPKAPK3 | 2.48432434 |
| 11 | MAPK15 | 2.47078790 |
| 12 | EPHA3 | 2.43717835 |
| 13 | KDR | 2.36849124 |
| 14 | PBK | 2.27827382 |
| 15 | DYRK2 | 2.26858563 |
| 16 | KIT | 2.08778074 |
| 17 | MINK1 | 2.06356991 |
| 18 | MAP3K11 | 2.04620531 |
| 19 | KSR2 | 2.01631567 |
| 20 | MATK | 2.01170158 |
| 21 | MAP4K2 | 1.98866087 |
| 22 | SIK2 | 1.91393598 |
| 23 | RET | 1.87582016 |
| 24 | SCYL2 | 1.85844718 |
| 25 | VRK1 | 1.80318339 |
| 26 | STK16 | 1.77632644 |
| 27 | MAP4K1 | 1.74356721 |
| 28 | TRIB3 | 1.74231381 |
| 29 | INSRR | 1.70230699 |
| 30 | FRK | 1.68205858 |
| 31 | LIMK1 | 1.64419206 |
| 32 | NTRK3 | 1.64242620 |
| 33 | FGFR4 | 1.62883688 |
| 34 | FLT3 | 1.62677658 |
| 35 | FES | 1.59654590 |
| 36 | WNK3 | 1.55280194 |
| 37 | RPS6KA2 | 1.54278649 |
| 38 | MAP3K1 | 1.54139107 |
| 39 | JAK3 | 1.51808480 |
| 40 | CDC7 | 1.49657068 |
| 41 | FGFR3 | 1.49640330 |
| 42 | MAP2K2 | 1.49147298 |
| 43 | MAP3K9 | 1.47249553 |
| 44 | MARK3 | 1.46353137 |
| 45 | JAK1 | 1.46013897 |
| 46 | NUAK1 | 1.44987725 |
| 47 | MST1R | 1.44780605 |
| 48 | ARAF | 1.35759688 |
| 49 | ZAP70 | 1.28627218 |
| 50 | PKN2 | 1.27888721 |
| 51 | CAMKK2 | 1.23627676 |
| 52 | MAP2K1 | 1.23462632 |
| 53 | MAP2K4 | 1.22855893 |
| 54 | PNCK | 1.22336465 |
| 55 | SIK3 | 1.20018411 |
| 56 | EPHB1 | 1.18792077 |
| 57 | CSF1R | 1.16854031 |
| 58 | TAOK1 | 1.16475555 |
| 59 | TNK2 | 1.16064661 |
| 60 | CDC42BPA | 1.15621931 |
| 61 | MAP3K10 | 1.13925081 |
| 62 | ATR | 1.13328600 |
| 63 | TXK | 1.11753738 |
| 64 | WNK1 | 1.10300062 |
| 65 | GRK5 | 1.09458573 |
| 66 | PRKG2 | 1.08702248 |
| 67 | PLK4 | 1.08397147 |
| 68 | MAPK13 | 1.07530928 |
| 69 | TYK2 | 1.05568597 |
| 70 | SGK3 | 1.05344509 |
| 71 | PRKCH | 1.02725101 |
| 72 | TLK1 | 1.01394910 |
| 73 | MAP3K12 | 0.99551049 |
| 74 | TAF1 | 0.98388564 |
| 75 | DYRK3 | 0.97747608 |
| 76 | DYRK1B | 0.97366379 |
| 77 | JAK2 | 0.97099875 |
| 78 | MUSK | 0.96811108 |
| 79 | AURKA | 0.96552758 |
| 80 | SGK2 | 0.94493800 |
| 81 | EEF2K | 0.94160242 |
| 82 | MAP3K14 | 0.93545059 |
| 83 | MAP2K3 | 0.92654029 |
| 84 | PRKD3 | 0.91604391 |
| 85 | HIPK2 | 0.90162339 |
| 86 | TAOK2 | 0.87884118 |
| 87 | TBK1 | 0.86015305 |
| 88 | FER | 0.85309995 |
| 89 | STK4 | 0.85250016 |
| 90 | BLK | 0.84755115 |
| 91 | PDK2 | 0.84382506 |
| 92 | SYK | 0.84361393 |
| 93 | STK24 | 0.80674557 |
| 94 | PTK2 | 0.79430153 |
| 95 | CDK12 | 0.79407609 |
| 96 | RPS6KA5 | 0.78643626 |
| 97 | BMPR1B | 0.76525936 |
| 98 | CSNK1G3 | 0.75488128 |
| 99 | ADRBK1 | 0.75152859 |
| 100 | TIE1 | 0.74563160 |
| 101 | ABL2 | 0.74007988 |
| 102 | TRPM7 | 0.73712841 |
| 103 | RPS6KA4 | 0.73679398 |
| 104 | SGK494 | 0.73588365 |
| 105 | SGK223 | 0.73588365 |
| 106 | PDK1 | 0.73216797 |
| 107 | DAPK1 | 0.72542691 |
| 108 | TAOK3 | 0.71319179 |
| 109 | CHEK2 | 0.70925624 |
| 110 | PHKG1 | 0.70386503 |
| 111 | PHKG2 | 0.70386503 |
| 112 | TEC | 0.69665610 |
| 113 | RPS6KB2 | 0.68477295 |
| 114 | LRRK2 | 0.68366674 |
| 115 | CAMKK1 | 0.67595095 |
| 116 | ZAK | 0.67550537 |
| 117 | SMG1 | 0.66751996 |
| 118 | PDGFRA | 0.66355964 |
| 119 | MAP3K4 | 0.65096111 |
| 120 | PDPK1 | 0.64937427 |
| 121 | BMX | 0.63782607 |
| 122 | SIK1 | 0.63019933 |
| 123 | PRKD2 | 0.62000490 |
| 124 | PIM2 | 0.61850087 |
| 125 | OBSCN | 0.61754204 |
| 126 | SRPK1 | 0.60904779 |
| 127 | PTK6 | 0.60599724 |
| 128 | MAP3K5 | 0.59745453 |
| 129 | IKBKB | 0.59644723 |
| 130 | NEK9 | 0.59559181 |
| 131 | ICK | 0.58569250 |
| 132 | LATS2 | 0.56744652 |
| 133 | TESK1 | 0.56290093 |
| 134 | IRAK3 | 0.55362576 |
| 135 | PIK3CA | 0.52324133 |
| 136 | BUB1 | 0.51981129 |
| 137 | CDK7 | 0.51347499 |
| 138 | AURKB | 0.48140187 |
| 139 | MET | 0.47946354 |
| 140 | MAP3K3 | 0.47010484 |
| 141 | PLK1 | 0.46923561 |
| 142 | BTK | 0.46290579 |
| 143 | CSNK1G2 | 0.46199720 |
| 144 | PRKAA1 | 0.46107342 |
| 145 | RIPK1 | 0.46062992 |
| 146 | CDK9 | 0.45678411 |
| 147 | PDGFRB | 0.45650166 |
| 148 | TTN | 0.44337736 |
| 149 | MAPKAPK2 | 0.44185817 |
| 150 | PASK | 0.43390254 |
| 151 | ADRBK2 | 0.43290967 |
| 152 | CSNK1A1L | 0.43104860 |
| 153 | MAPK11 | 0.42228960 |
| 154 | MST4 | 0.41963851 |
| 155 | ITK | 0.41907865 |
| 156 | IRAK1 | 0.41648261 |
| 157 | PRKCI | 0.40626330 |
| 158 | LCK | 0.39931576 |
| 159 | CSNK1G1 | 0.39022139 |
| 160 | IRAK4 | 0.38648336 |
| 161 | MARK2 | 0.38536270 |
| 162 | CDK5 | 0.37831319 |
| 163 | UHMK1 | 0.37251003 |
| 164 | IKBKE | 0.37066210 |
| 165 | PRKCQ | 0.37036970 |
| 166 | CSK | 0.35671565 |
| 167 | WNK4 | 0.35412111 |
| 168 | LYN | 0.35279006 |
| 169 | RPS6KA6 | 0.34988620 |
| 170 | MAP3K7 | 0.34896008 |
| 171 | NME1 | 0.34689918 |
| 172 | GRK6 | 0.34350776 |
| 173 | CSNK2A2 | 0.33803512 |
| 174 | CSNK2A1 | 0.31241366 |
| 175 | PRKCD | 0.30603029 |
| 176 | RPS6KA1 | 0.30174537 |
| 177 | MAP2K7 | 0.29352140 |
| 178 | PKN1 | 0.29073624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RNA polymerase_Homo sapiens_hsa03020 | 4.05023283 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.65189240 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.60623097 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.49112464 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 3.44813579 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 3.38300447 |
| 7 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.00055991 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.90080773 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.82904274 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.56572062 |
| 11 | Proteasome_Homo sapiens_hsa03050 | 2.45741956 |
| 12 | Huntingtons disease_Homo sapiens_hsa05016 | 2.41280373 |
| 13 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.24391163 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.22671196 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.22619880 |
| 16 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.20891604 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.18463755 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.18371954 |
| 19 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.15411013 |
| 20 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.13737139 |
| 21 | Alzheimers disease_Homo sapiens_hsa05010 | 2.11596550 |
| 22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.06916261 |
| 23 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.96603318 |
| 24 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.95802720 |
| 25 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.92607040 |
| 26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.87253506 |
| 27 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.85127040 |
| 28 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.84149682 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.83510551 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.79079208 |
| 31 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.77091078 |
| 32 | Thyroid cancer_Homo sapiens_hsa05216 | 1.74322133 |
| 33 | Spliceosome_Homo sapiens_hsa03040 | 1.70640838 |
| 34 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.62050621 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.59582927 |
| 36 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.59254845 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55326750 |
| 38 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.46952645 |
| 39 | Purine metabolism_Homo sapiens_hsa00230 | 1.46711984 |
| 40 | Mismatch repair_Homo sapiens_hsa03430 | 1.42442350 |
| 41 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.42036540 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.41869549 |
| 43 | Insulin resistance_Homo sapiens_hsa04931 | 1.38324633 |
| 44 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.38184097 |
| 45 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.36689989 |
| 46 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.29875760 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.28648310 |
| 48 | Taste transduction_Homo sapiens_hsa04742 | 1.26093321 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.25285230 |
| 50 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.23955136 |
| 51 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.22694234 |
| 52 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.20249663 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.17611544 |
| 54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.16774580 |
| 55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.14903982 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 1.13356476 |
| 57 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.12082580 |
| 58 | Leishmaniasis_Homo sapiens_hsa05140 | 1.10571439 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.10312593 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.10070745 |
| 61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.09508901 |
| 62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.08758569 |
| 63 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.07995703 |
| 64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.06122230 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 1.01499964 |
| 66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00300468 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99537084 |
| 68 | Bile secretion_Homo sapiens_hsa04976 | 0.99428151 |
| 69 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.98120852 |
| 70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98084626 |
| 71 | Glioma_Homo sapiens_hsa05214 | 0.95498912 |
| 72 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.94182723 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.92745425 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92710179 |
| 75 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.91264980 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.90764586 |
| 77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.90122038 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.89927849 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.88285715 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.88022254 |
| 81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.87856140 |
| 82 | Apoptosis_Homo sapiens_hsa04210 | 0.87068795 |
| 83 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.86138517 |
| 84 | Tuberculosis_Homo sapiens_hsa05152 | 0.85838816 |
| 85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85333831 |
| 86 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84850797 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84775617 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.84748716 |
| 89 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84608101 |
| 90 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83290511 |
| 91 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.83221959 |
| 92 | Phototransduction_Homo sapiens_hsa04744 | 0.83179275 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.83167981 |
| 94 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.82533995 |
| 95 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.82375630 |
| 96 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81958892 |
| 97 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80669314 |
| 98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.80144317 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80111969 |
| 100 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79880242 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79833550 |
| 102 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79044608 |
| 103 | Asthma_Homo sapiens_hsa05310 | 0.78481365 |
| 104 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.77589199 |
| 105 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.76081899 |
| 106 | Influenza A_Homo sapiens_hsa05164 | 0.74674337 |
| 107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.74001068 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.72921014 |
| 109 | Long-term potentiation_Homo sapiens_hsa04720 | 0.72369832 |
| 110 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71963589 |
| 111 | Allograft rejection_Homo sapiens_hsa05330 | 0.71615587 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71531839 |
| 113 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71477092 |
| 114 | Pertussis_Homo sapiens_hsa05133 | 0.70971671 |
| 115 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70809112 |
| 116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69940135 |
| 117 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69780168 |
| 118 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.69457940 |
| 119 | Lysosome_Homo sapiens_hsa04142 | 0.68540010 |
| 120 | RNA transport_Homo sapiens_hsa03013 | 0.68380968 |
| 121 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67969829 |
| 122 | Phagosome_Homo sapiens_hsa04145 | 0.67575852 |
| 123 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67210461 |
| 124 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67081840 |
| 125 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.66317574 |
| 126 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64929290 |
| 127 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64588392 |
| 128 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.64585230 |
| 129 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63143124 |
| 130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61986780 |
| 131 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61963519 |
| 132 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.61696170 |
| 133 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.61091586 |
| 134 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60965479 |
| 135 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59929425 |
| 136 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59397559 |
| 137 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59254282 |
| 138 | Bladder cancer_Homo sapiens_hsa05219 | 0.59247977 |
| 139 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58737295 |
| 140 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58622990 |
| 141 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58255176 |
| 142 | Endocytosis_Homo sapiens_hsa04144 | 0.57324272 |
| 143 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55763086 |
| 144 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55473357 |
| 145 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55095412 |
| 146 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54216675 |
| 147 | Olfactory transduction_Homo sapiens_hsa04740 | 0.53527329 |
| 148 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53521119 |
| 149 | Salivary secretion_Homo sapiens_hsa04970 | 0.53469217 |
| 150 | Hepatitis B_Homo sapiens_hsa05161 | 0.53177863 |
| 151 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.52841923 |
| 152 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.52657532 |
| 153 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52146714 |
| 154 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.52128536 |
| 155 | Nicotine addiction_Homo sapiens_hsa05033 | 0.52071858 |
| 156 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.51767666 |
| 157 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51589046 |
| 158 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50882854 |
| 159 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.50878721 |
| 160 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49569101 |
| 161 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49303311 |
| 162 | Prion diseases_Homo sapiens_hsa05020 | 0.48243162 |
| 163 | Legionellosis_Homo sapiens_hsa05134 | 0.47487962 |
| 164 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.47486809 |
| 165 | RNA degradation_Homo sapiens_hsa03018 | 0.47084293 |
| 166 | Amoebiasis_Homo sapiens_hsa05146 | 0.46630147 |
| 167 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46320520 |
| 168 | Alcoholism_Homo sapiens_hsa05034 | 0.46089936 |
| 169 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44951264 |
| 170 | Protein export_Homo sapiens_hsa03060 | 0.42843348 |
| 171 | Cell cycle_Homo sapiens_hsa04110 | 0.42569513 |
| 172 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.42275964 |
| 173 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37196426 |
| 174 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.36579254 |
| 175 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35998196 |
| 176 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.33365661 |
| 177 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.33025443 |
| 178 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.31229841 |
| 179 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.30395418 |
| 180 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.28398019 |
| 181 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.27959617 |
| 182 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.27859323 |
| 183 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.25411953 |
| 184 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.24966941 |
| 185 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.18787885 |
| 186 | Basal transcription factors_Homo sapiens_hsa03022 | 0.14827391 |

